sprite-preloader
Anzeige
Mehr »
Sonntag, 17.02.2019 Börsentäglich über 12.000 News von 595 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von Endpoints News

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrTropical disease PRV fix didn't stop Novartis from winning another
FrFDA doc reveals agency charged Immunomedics with data integrity breach after August plant inspection
FrJ&J R&D vet Peter Tummino joins the Big Pharma exodus, leaping to Nimbus as CSO; Cadent taps Jodie Morrison for CEO
FrGW Pharma cannabinoid to be tested for Alzheimer's agitation; Acorda revenue plummets as generics eviscerate its franchise
FrMorningside spawned Stealth Bio's IPO stumbles out of the gate, raising $78M
FrBayer, Orion prostate cancer drug cuts risk of metastasis or death by more than 50% in key study
FrJames Wilson turns to old mentor for gene therapy startup's star-studded $115M launch round
FrThe top 10 pipeline blowups, setbacks and snafus for H2 2018
FrIndia's generic drug maker Glenmark draws up a US-based branded drugs unit
FrAppropriations bill would give FDA $269M boost over FY2018 budget
DoMerck goes in deeper with Keytruda/Lynparza combo; PureTech unveils stem cell therapy startup
DoAntipsychotic from Lundbeck, Otsuka flops again in PhIII trials - this time in bipolar patients
DoMotif Bio's turnaround quest for once-rejected antibiotic hits the CRL wall
DoVivek Ramaswamy whips up a CNS spinoff with a $530M deal and a syndicate of supporters
DoDavid de Graaf has a new gig, a new idea and a new startup - hunting some new money
DoAstraZeneca drops an OX40 cancer drug candidate in Q4 pipeline cleanup
DoDBV estimates peanut allergy drug submission in Q3, but it may be too little too late in race with Aimmune
DoIn HKEX's first test in 2019, CStone seeks up to $304M in IPO fortune
DoAstraZeneca sweeps away the MedImmune name as CEO Soriot restructures R&D
DoDonated globally since 2005, Novartis' flatworm treatment Egaten wins FDA nod - and a PRV
MiCharles River drops $510M to bag non-clinical CRO; Magpie raises $14.8M Series B to modernize traditional Chinese meds
MiVas Narasimhan earned a big pay hike when he moved to the CEO's suite at Novartis
MiJ&J to augment surgical offerings with $3.4B acquisition of robotics firm Auris Health
MiBusy VC 5AM eclipses $125M target for fund to inject capital into existing portfolio, meets goal for sixth biotech fund - report
MiThe $100M biotech club: Who's in, and what's it take to join the top-performing group of biopharmas?